Viva Biotech And HQL Pharmaceuticals Join Forces To Form Powerhouse For Structure - And Fragment - Based Drug Discovery
3/5/2014 9:21:05 AM
SHANGHAI & REHOVOT, Israel.--(BUSINESS WIRE)--Viva Biotech Ltd., a leading company in structure-based and fragment based drug discovery services, based in Shanghai, China, and HQL Pharmaceuticals Ltd., a drug discovery company utilizing its super-power proprietary ChemSpace Scanner (CSS™) computational technology, based in Rehovot, Israel, today announced that they have entered into a strategic alliance to jointly provide a fully-integrated drug discovery services, focused on leads generation based on fragment screening.
Help employers find you! Check out all the jobs and post your resume.
comments powered by